Feed Preview

Fast Growing

ALS: Therapies

ALS: Therapies diagram by Vaccinationist, Wikimedia
Vaccinationist, Wikimedia

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Top 20 most recent papers
Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics

Pharmacological BACE Inhibition Improves Axonal Regeneration in Nerve Injury and Disease Models

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeuticsApril 3, 2020
Carolyn TallonMohamed H Farah
1
International Journal of Molecular Sciences

Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice

International Journal of Molecular SciencesApril 5, 2020
Elisabetta BonfantiMarta Fumagalli
1
International Journal of Molecular Sciences

Insights into the Therapeutic Potential of Glucocorticoid Receptor Modulators for Neurodegenerative Diseases

International Journal of Molecular SciencesApril 5, 2020
Alejandro F De NicolaMaria Claudia Gonzalez Deniselle
Expert Opinion on Pharmacotherapy

Advances in disease-modifying pharmacotherapies for the treatment of amyotrophic lateral sclerosis

Expert Opinion on PharmacotherapyApril 4, 2020
R HergesheimerP Couratier
Biological Chemistry

The MICOS complex, a structural element of mitochondria with versatile functions

Biological ChemistryApril 2, 2020
Siavash Khosravi, Max E Harner
1
1
Biochemical and Biophysical Research Communications

Dipeptide repeat derived from C9orf72 hexanucleotide expansions forms amyloids or natively unfolded structures in vitro

Biochemical and Biophysical Research CommunicationsApril 1, 2020
Laurent BrasseurLuc Bousset
2
1
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration

VRK1 variants in two Portuguese unrelated patients with childhood-onset motor neuron disease

Amyotrophic Lateral Sclerosis & Frontotemporal DegenerationApril 4, 2020
Daniela Pimenta SilvaMamede de Carvalho
Bioorganic & Medicinal Chemistry

Chemical reactivity and uses of 1-phenyl-3-methyl-5-pyrazolone (PMP), also known as edaravone

Bioorganic & Medicinal ChemistryApril 4, 2020
Christian BaillyJean-François Goossens
Neurobiology of Disease

Effects of exercise on sleep in neurodegenerative disease

Neurobiology of DiseaseApril 4, 2020
Adeel A MemonAmy W Amara
27
Neurotoxicity Research

Energy Balance as a Moderator of Neurologic Disease Risk and Progression

Neurotoxicity ResearchMarch 28, 2020
Daniel L Smith, Gregory Pavela
4
1
Brain Research Bulletin

IN VITRO AND IN VIVO MODELS OF AMYOTROPHIC LATERAL SCLEROSIS: AN UPDATED OVERVIEW

Brain Research BulletinApril 6, 2020
Auderlan M GoisJose R Santos
Neurology. Neuroimmunology and Neuroinflammation

RNA-binding protein altered expression and mislocalization in MS

Neurology. Neuroimmunology and NeuroinflammationMarch 29, 2020
Katsuhisa MasakiRaymond P Roos
2
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia

Possible therapies of Parkinson's disease: A review

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of AustralasiaApril 6, 2020
Ashok ChakrabortyAnil Diwan
Journal of Cellular Physiology

Glucose, glycolysis, and neurodegenerative diseases

Journal of Cellular PhysiologyApril 3, 2020
Bor Luen Tang
6
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons

Fusion of the Tarsometatarsal Joints: A Focus on Lateral Column Fusion Nonunion Rates

The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle SurgeonsApril 5, 2020
Richard DernerAnsgar Olsen

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/als-therapies/70cf9704-ab72-4a54-b1b1-b2e7d895a2cc